In September 2024, Luye Pharma Group (Yantai Branch) came to our company to audit the related parts of nuclear magnetism. Finally passed the customer's audit and won unanimous praise.
In September 2024
In september 2024, Haohai Guangjie successfully passed the CNAS additional assessment.
In September 2024
In September 2023, Haohai Guangjie passed the CNAS review successfully.
In September 2023
Qingdao Haohai Guangjie Testing and Technical Consulting Co., Ltd successfully signed a contract with Qingdao Inspection and Quarantine Technology Development Center in January 2021.
in January 2021
Qingdao Haohai Guangjie Testing and Technical Consulting Co., Ltd laboratory has successfully passed the CMA on-site review in January 2021 and obtained the CMA certificate in February!
In January 2021
Academician Cao Yihai, a strategic partner of our company, published a heavyweight academic paper "Efficacy and tolerability of bevacizumab in patients with severe COVID-19" in the international top a
In January 2021
In December 2020, HHGJ participated in the 20th CPhI & P-MEC China in Shanghai as an exhibitor.
In December 2020
In June 2020, the Haohai Laboratory was officially put into operation.
In June 2020
In August 2020, Qingdao Haohai Guangjie Testing and Technical Consulting Co., Ltd signed a strategic cooperation agreement with the University of Bologna.
In August 2020
In September 2020, Qingdao Haohai Guangjie Testing and Technical Consulting Co., Ltd laboratory get the construction of cGMP system started.
In September 2020
In April 2019, Qingdao Haohai Guangjie Pharmaceutical Technology Co., Ltd. is established.
In April 2019
In August 2019, Qingdao Haohai Guangjie Testing and Technical Consulting Co., Ltd reached a strategic cooperation with Rouhigh Group.
In August 2019
